ISRCTN51663857
Completed
未知
Anticoagulation following tissue aortic valve replacement
St George's Healthcare NHS Trust (UK)0 sites400 target enrollmentApril 10, 2006
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Aortic valve disease
- Sponsor
- St George's Healthcare NHS Trust (UK)
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing tissue aortic valve replacement
Exclusion Criteria
- •1\. Patients who require aspirin or warfarin therapy on established medical grounds
- •2\. Patients unable to take warfarin or aspirin
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
APT trialaortic stenosisASJPRN-jRCTs031220614Hayashida Kentaro360
Active, not recruiting
Phase 1
Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with the help of anticoagulant medications.ew-Onset Post-Operative Atrial Fibrillation afterCABGMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2021-005022-18-DEIcahn School of Medicine at Mount Sinai3,200
Recruiting
Phase 1
Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with the help of anticoagulant medications.CTIS2024-515924-35-00Icahn School Of Medicine At Mount Sinai3,200
Completed
Not Applicable
Observatory of Anticoagulation After Bioprosthetic Aortic Valve ReplacementAortic Valve DiseaseNCT01293188French Cardiology Society434
Recruiting
Not Applicable
Surgical Replacement and Transcatheter Aortic Valve Implantation Trial 10 Year Follow-upsevere aortic valve stenosis10046973NL-OMON45149Medtronic B.V.160